Clinical Ink is partnering with a “leading biopharmaceutical organization” to monitor symptoms of people with Parkinson’s disease at…
Articles by Marisa Wexler, MS
Top-line results are expected next month from a Phase 2b clinical trial testing whether the investigational oral therapy mesdopetam can…
Nitrase Therapeutics has partnered with HitGen in the search for novel therapies that suppress nitrases, a class of…
The U.S. Food and Drug Administration (FDA) has put a hold on clinical trials of IkT-148009, an experimental oral therapy…
NeuroOne Medical Technologies announced it has successfully completed a feasibility study of its OneRF ablation system, which uses implanted…
BioVie’s investigational oral therapy NE3107, taken in combination with standard levodopa, eases motor symptoms more substantially than levodopa alone…
More than 30% of gut microbial species are found at abnormal numbers in Parkinson’s disease patients, according to a new…
Pairing at-home healthcare visits with peer mentoring may help to prevent the strain of caregiving from worsening over time among…
An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to…
New machine learning models based on walking patterns accurately distinguished between Parkinson’s patients and healthy people, and between different…